WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007013670) GENE GALNT6 AS BREAST CANCER MARKER AND SMALL INTERFERING RNAS DIRECTED AGAINST GENE GALNT6
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/013670    International Application No.:    PCT/JP2006/315341
Publication Date: 01.02.2007 International Filing Date: 26.07.2006
IPC:
C12Q 1/68 (2006.01), C12N 15/11 (2006.01), C07K 16/32 (2006.01)
Applicants: ONCOTHERAPY SCIENCE, INC. [JP/JP]; 2-1, Sakado 3-chome, Takatsu-ku, Kawasaki-shi, Kanagawa, 2130012 (JP) (For All Designated States Except US).
NAKAMURA, Yusuke [JP/JP]; (JP) (For US Only).
KATAGIRI, Toyomasa [JP/JP]; (JP) (For US Only).
NAKATSURU, Shuichi [JP/JP]; (JP) (For US Only)
Inventors: NAKAMURA, Yusuke; (JP).
KATAGIRI, Toyomasa; (JP).
NAKATSURU, Shuichi; (JP)
Agent: SHIMIZU, Hatsushi; Kantetsu Tsukuba Bldg. 6F, 1-1-1, Oroshi-machi, Tsuchiura-shi, Ibaraki 3000847 (JP)
Priority Data:
60/703,658 29.07.2005 US
Title (EN) GENE GALNT6 AS BREAST CANCER MARKER AND SMALL INTERFERING RNAS DIRECTED AGAINST GENE GALNT6
(FR) GENE ET POLYPEPTIDE LIES AU CANCER DU SEIN
Abstract: front page image
(EN)The present application provides novel human gene GALNT6 whose expression is markedly elevated in breast cancers. The gene and polypeptide encoded by the gene can be used, for example, in the diagnosis of breast cancers, as target molecules for developing drugs against the disease, such as siRNAS, and for attenuating cell growth of breast cancer.
(FR)La présente invention a trait un nouveau gène B7330N humain dont l'expression est nettement élevé dans des cancers du sein. Le gène et le polypeptide codés par le gène peut être utilisé, par exemple, dans le diagnostic de cancers du sein, comme molécules cibles pour le développement de médicaments contre la maladie, et pour l'atténuation de la croissance cellulaire du cancer du sein.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)